Here's Why Cencora (COR) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Sep 18, 2026

Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

Here's Why Cencora (COR) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Sep 10, 2026

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha • Sep 8, 2026

Why Cencora (COR) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Sep 7, 2026

Cencora Launches Cell and Gene Therapy Enablement for Health Systems

COR launches CGT Enablement to help health systems build and scale cell and gene therapy programs with financial, operational and access support.

Zacks Investment Research • Sep 4, 2026

Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?

Cencora (COR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 4, 2026

Here's Why You Should Retain Cencora Stock in Your Portfolio for Now

Cencora's specialty momentum, OneOncology growth and GLP-1 volumes offer upside, but drug-price cuts and MWI risks cloud its outlook.

Zacks Investment Research • Sep 4, 2026

Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen

Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.

Zacks Investment Research • Sep 3, 2026